Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Best, Jan [VerfasserIn]   i
 Bechmann, Lars Peter [VerfasserIn]   i
 Sowa, Jan-Peter [VerfasserIn]   i
 Sydor, Svenja [VerfasserIn]   i
 Dechêne, Alexander [VerfasserIn]   i
 Pflanz, Kristina [VerfasserIn]   i
 Bedreli, Sotiria [VerfasserIn]   i
 Schotten, Clemens [VerfasserIn]   i
 Geier, Andreas [VerfasserIn]   i
 Berg, Thomas [VerfasserIn]   i
 Fischer, Janett [VerfasserIn]   i
 Vogel, Arndt [VerfasserIn]   i
 Bantel, Heike [VerfasserIn]   i
 Weinmann, Arndt [VerfasserIn]   i
 Schattenberg, Jörn Markus [VerfasserIn]   i
 Huber, Yvonne [VerfasserIn]   i
 Wege, Henning [VerfasserIn]   i
 Felden, Johann von [VerfasserIn]   i
 Schulze, Kornelius [VerfasserIn]   i
 Bettinger, Dominik [VerfasserIn]   i
 Thimme, Robert [VerfasserIn]   i
 Sinner, Friedrich [VerfasserIn]   i
 Schütte, Kerstin [VerfasserIn]   i
 Weiss, Karl Heinz [VerfasserIn]   i
 Toyoda, Hidenori [VerfasserIn]   i
 Yasuda, Satoshi [VerfasserIn]   i
 Kumada, Takashi [VerfasserIn]   i
 Berhane, Sarah [VerfasserIn]   i
 Wichert, Marc [VerfasserIn]   i
 Heider, Dominik [VerfasserIn]   i
 Gerken, Guido [VerfasserIn]   i
 Johnson, Philip [VerfasserIn]   i
 Canbay, Ali E. [VerfasserIn]   i
Titel:GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis
Verf.angabe:Jan Best, Lars P. Bechmann, Jan-Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip Johnson, Ali Canbay
Jahr:2020
Jahr des Originals:2019
Umfang:8 S.
Fussnoten:Available online 8 November 2019 ; Gesehen am 15.04.2020
Titel Quelle:Enthalten in: Clinical gastroenterology and hepatology
Ort Quelle:New York, NY : Elsevier Science, 2003
Jahr Quelle:2020
Band/Heft Quelle:18(2020), 3, Seite 728-735.e4
ISSN Quelle:1542-7714
Abstract:Background & Aims - The prevalence of nonalcoholic steatohepatitis (NASH) associated hepatocellular carcinoma (HCC) is increasing. However, strategies for detection of early-stage HCC in patients with NASH have limitations. We assessed the ability of the GALAD score, which determines risk of HCC based on patient sex; age; and serum levels of α-fetoprotein (AFP), AFP isoform L3 (AFP-L3), and des-gamma-carboxy prothrombin (DCP), to detect HCC in patients with NASH. - Methods - We performed a case-control study of 125 patients with HCC (20% within Milan Criteria) and 231 patients without HCC (NASH controls) from 8 centers in Germany. We compared the performance of serum AFP, AFP-L3, or DCP vs GALAD score to identify patients with HCC using receiver operating characteristic curves and corresponding area under the curve (AUC) analyses. We also analyzed data from 389 patients with NASH under surveillance for HCC in Japan, followed for a median of 167 months. During the 5-year screening period, 26 patients developed HCC. To compensate for irregular intervals of data points, we performed locally weighted scatterplot smoothing, linear regression, and a non-linear curve fit to assess development of GALAD before HCC development. - Results - The GALAD score identified patients with any stage HCC with an AUC of 0.96 — significantly greater than values for serum levels of AFP (AUC, 0.88), AFP-L3 (AUC, 0.86) or DCP (AUC, 0.87). AUC values for the GALAD score were consistent in patients with cirrhosis (AUC, 0.93) and without cirrhosis (AUC, 0.98). For detection of HCC within Milan Criteria, the GALAD score achieved an AUC of 0.91, with a sensitivity of 68% and specificity of 95% at a cutoff of -0.63. In a pilot Japanese cohort study, the mean GALAD score was higher in patients with NASH who developed HCC than in those who did not develop HCC as early as 1.5 years before HCC diagnosis. GALAD scores were above -0.63 approximately 200 days before the diagnosis of HCC. - Conclusions - In a case-control study performed in Germany and a pilot cohort study in Japan, we found the GALAD score may detect HCC with high levels of accuracy in patients with NASH, with and without cirrhosis. The GALAD score can detect patients with early-stage HCC, and might facilitate surveillance of patients with NASH, who are often obese, which limits the sensitivity of detection of liver cancer by ultrasound.
DOI:doi:10.1016/j.cgh.2019.11.012
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Kostenfrei: Volltext ; Verlag: https://doi.org/10.1016/j.cgh.2019.11.012
 Kostenfrei: Volltext: http://www.sciencedirect.com/science/article/pii/S1542356519312674
 DOI: https://doi.org/10.1016/j.cgh.2019.11.012
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Diagnostic
 NAFLD
 Serologic Assay
 Test
 Tumor
K10plus-PPN:1694610179
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68564648   QR-Code
zum Seitenanfang